Abstract
Abilify MyCite, a pill that includes a digital sensor that can track medication adherence, was approved by the US Food and Drug Administration in November 2017.[1][1] The pill’s sensor communicates with an external patch, which transmits information on whether the pill has been ingested to a
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
